Treatment of Depression after stroke in Unani Medicine

Efficacy of Sumbul-Ut-Teeb in Post Stroke Depression: A Randomized, Double blind, Controlled Trial - DPN

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031410

Enrollment

Registered

2021-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F31- Bipolar disorder Health Condition 2: F318- Other bipolar disorders

Interventions

Intervention1: Sumbul-ut-teeb: Fine powder of Sumbul-ut-teeb 3gm will be given orally in capsules, daily in two divided doses for 6 weeks. Placebo (roasted wheat flour)will be given in the same manner

Eligibility

Inclusion criteria

Inclusion criteria: Patients exhibiting depression, as assessed by the International Classification of Diseases, 10th Revision (ICD-10). Patients age >18 yrs of either gender. Patients having single ischaemic or haemorrhagic stroke documented by cerebral CT scanning or MRI before enrolment. Patients having history of stroke > 3months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
â?¢Reduction in Hamilton Depression Rating Scale (HDRS17) ScoreTimepoint: fortnightly for 6 weeks. (0, 14th , 28th , and 42nd day)	—

Secondary

Measure	Time frame
â?¢Improvement in subjective parameters â?¢Improvement in quality of life Timepoint: fortnightly for 6 weeks. (0, 14th , 28th , and 42nd day)	—

Countries

India

Contacts

Public ContactHusain Ahmad

National Institute of Unani Medicine

drmuzaffar79@gmail.com9590366192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026